Let’s Talk About a Smarter Way to Stay Protected
The world of sexual health is evolving. While the fight against HIV, sexually transmitted infections (STIs), and unintended pregnancies continues, there’s a new frontier making waves in prevention science: Multipurpose Prevention Technologies, or MPTs.
MPTs are innovative products designed to address multiple sexual and reproductive health needs in one go. Imagine a single device, pill, or gel that can protect against HIV, prevent other STIs, and offer contraception. For many, this isn’t just convenient — it’s transformative.
Why Should Anyone Care About MPTs?
- The World Health Organization estimates more than 1 million STIs are acquired every day worldwide.
- UNAIDS reports nearly 39 million people are living with HIV as of 2023.
- In Singapore, the Ministry of Health reported 188 new HIV cases among residents between January and October 2023, with sexual transmission accounting for 96% of cases. Nearly half were diagnosed at a late stage — a slight improvement from the year before
- Over 218 million women worldwide have an unmet need for modern contraception.
That’s where MPTs come in — offering an all-in-one solution that simplifies protection and improves adherence.
So What Exactly Are These MPTs?
a) Intravaginal Rings (IVRs)
Flexible silicone rings inserted into the vagina, IVRs release a controlled dose of drugs over weeks or months.
- Dapivirine + Levonorgestrel Ring: Prevents HIV and pregnancy.
- EEQ Ring: Combines contraceptive and antiviral agents.
How it works:
- Long-acting (1–3 months)
- User-controlled and discreet
- Doesn’t interrupt spontaneity
b) Topical Gels and Films
- Tenofovir-based gels: For HIV and herpes prevention.
- Combination gels: In testing for dual protection.
How it works:
- Use as needed
- Easy to apply
- Some may be OTC
c) Long-Acting Injectables
These combine hormonal contraceptives and PrEP in a single shot.
- Cabotegravir + Medroxyprogesterone acetate is a promising candidate.
How it works:
- Lasts 2–3 months
- Minimal visits needed
d) Implants
Still in early development but could deliver antiretrovirals and contraceptives over long durations.
- Long-term (6–12 months)
- Set-and-forget simplicity
e) Other Emerging Formats
- Fast-dissolving vaginal inserts
- Nanofiber meshes
- Multipurpose skin patches
Who’s Going to Benefit the Most?
- Women and girls in high-prevalence regions
- Young adults with inconsistent protection
- Sex workers and transactional partners
- Trans and MSM communities
- Underserved populations
The Roadblocks: What’s Slowing It Down?
- Scientific complexity: Different drug profiles, delivery times.
- Regulatory layers: Must pass dual safety benchmarks.
- Distribution challenges: Cost and access barriers.
- Low public awareness: Education is still catching up.
- Social/cultural barriers: Stigma, norms, and misinformation.
What’s in the Works Right Now?
- Dapivirine + Levonorgestrel IVR: In Phase III trials.
- Tenofovir + contraceptive gel: Late-stage development.
- Cabotegravir + hormonal injectables: Early but promising.
More products are being tested on broader demographics beyond cisgender women.
Why We’re Watching This Closely
MPTs represent a big step forward: a way to offer protection that’s not just effective, but also easy, discreet, and empowering.
At Shim Clinic, we’re ready for this future. Until MPTs arrive, we’re here with HIV PrEP, HIV PEP, and STI screening — and we’ll help you build a prevention plan that fits your life.